These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10411457)

  • 1. Peptide-oligonucleotide phosphorothioate conjugates with membrane translocation and nuclear localization properties.
    Antopolsky M; Azhayeva E; Tengvall U; Auriola S; Jääskeläinen I; Rönkkö S; Honkakoski P; Urtti A; Lönnberg H; Azhayev A
    Bioconjug Chem; 1999; 10(4):598-606. PubMed ID: 10411457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stepwise synthesis of oligonucleotide-peptide conjugates containing guanidinium and lipophilic groups in their 3'-termini.
    Grijalvo S; Terrazas M; Aviñó A; Eritja R
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2144-7. PubMed ID: 20206515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense inhibition of human telomerase by phosphorothioate oligonucleotide-peptide conjugates.
    Diala I; Murao S; Fujii M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):679-80. PubMed ID: 18776562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of chimeric oligonucleotides containing phosphodiester, phosphorothioate, and phosphoramidate linkages.
    Maier MA; Guzaev AP; Manoharan M
    Org Lett; 2000 Jun; 2(13):1819-22. PubMed ID: 10891166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled intracellular localization and enhanced antisense effect of oligonucleotides by chemical conjugation.
    Kubo T; Zhelev Z; Bakalova R; Ohba H; Doi K; Fujii M
    Org Biomol Chem; 2005 Sep; 3(18):3257-9. PubMed ID: 16132084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent protein-oligonucleotide conjugates for efficient delivery of antisense molecules.
    Rajur SB; Roth CM; Morgan JR; Yarmush ML
    Bioconjug Chem; 1997; 8(6):935-40. PubMed ID: 9404669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of oligonucleotide-peptide conjugates for biomedical and technological applications.
    Aviñó A; Grijalvo S; Pérez-Rentero S; Garibotti A; Terrazas M; Eritja R
    Methods Mol Biol; 2011; 751():223-38. PubMed ID: 21674334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
    Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of antisense effect studied by functionalized oligonucleotides.
    Murakami A; Yoshimoto A; Furumoto A; Namba M; Yamaoka T
    Nucleic Acids Symp Ser; 1995; (34):229-30. PubMed ID: 8841635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular uptake and inhibition of gene expression by PNAs and PNA-peptide conjugates.
    Kaihatsu K; Huffman KE; Corey DR
    Biochemistry; 2004 Nov; 43(45):14340-7. PubMed ID: 15533038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of an oligonucleotide N3'-->P5' phosphoramidate/phosphorothioate chimera with capillary gel electrophoresis.
    DeDionisio LA; Raible AM; Nelson JS
    Electrophoresis; 1998 Nov; 19(16-17):2935-8. PubMed ID: 9870392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and evaluation of mitomycin-tethered phosphorothioate oligodeoxynucleotides.
    Huh N; Rege AA; Yoo B; Kogan TP; Kohn H
    Bioconjug Chem; 1996; 7(6):659-69. PubMed ID: 8950485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of nuclear targeting peptide-antisense oligodeoxynucleotide conjugates.
    Reed MW; Fraga D; Schwartz DE; Scholler J; Hinrichsen RD
    Bioconjug Chem; 1995; 6(1):101-8. PubMed ID: 7711095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel universal linker for efficient synthesis of phosphorothioate oligonucleotides.
    Wang Z; Olsen P; Ravikumar VT
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(3):259-69. PubMed ID: 17454735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles.
    Liu Y; Franzen S
    Bioconjug Chem; 2008 May; 19(5):1009-16. PubMed ID: 18393455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differential influence of non-iodinated and mono- or diiodinated benzoic acids on cellular and nuclear uptake of the nuclear localization sequence of the SV 40 T antigen.
    Heckl S; Sturzu A; Regenbogen M; Beck A; Gharabaghi A; Echner H
    Int J Pharm; 2008 May; 355(1-2):131-40. PubMed ID: 18249512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An alternative advantageous protocol for efficient synthesis of phosphorothioate oligonucleotides utilizing phenylacetyl disulfide (PADS).
    Kumar RK; Olsen P; Ravikumar VT
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(2):181-8. PubMed ID: 17365796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient DNA binding and nuclear uptake by distamycin derivatives conjugated to octa-arginine sequences.
    Vázquez O; Blanco-Canosa JB; Vázquez ME; Martínez-Costas J; Castedo L; Mascareñas JL
    Chembiochem; 2008 Nov; 9(17):2822-9. PubMed ID: 18942688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex formation and vectorization of a phosphorothioate oligonucleotide with an amphipathic leucine- and lysine-rich peptide: study at molecular and cellular levels.
    Boukhalfa-Heniche FZ; Hernández B; Gaillard S; Coïc YM; Huynh-Dinh T; Lecouvey M; Seksek O; Ghomi M
    Biopolymers; 2004 Apr; 73(6):727-34. PubMed ID: 15048776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugation of an antisense oligodeoxynucleotide to ribonuclease h results in sequence-specific cleavage and intracellular inhibition of HCV gene expression.
    Fukuma T; Walton CM; Wu CH; Wu GY
    Bioconjug Chem; 2003; 14(2):295-301. PubMed ID: 12643739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.